Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does EVOLOCUMAB Cause Leukaemia? 11 Reports in FDA Database

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

According to the FDA Adverse Event Reporting System (FAERS), 11 reports of Leukaemia have been filed in association with EVOLOCUMAB (REPATHA). This represents 0.0% of all adverse event reports for EVOLOCUMAB.

11
Reports of Leukaemia with EVOLOCUMAB
0.0%
of all EVOLOCUMAB reports
1
Deaths
2
Hospitalizations

How Dangerous Is Leukaemia From EVOLOCUMAB?

Of the 11 reports, 1 (9.1%) resulted in death, 2 (18.2%) required hospitalization, and 1 (9.1%) were considered life-threatening.

Is Leukaemia Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for EVOLOCUMAB. However, 11 reports have been filed with the FAERS database.

What Other Side Effects Does EVOLOCUMAB Cause?

Device difficult to use (31,807) Drug dose omission by device (23,957) Wrong technique in product usage process (21,664) Accidental exposure to product (16,160) Injection site pain (9,988) Product storage error (6,606) Back pain (5,254) Myalgia (5,061) Drug dose omission (4,914) Injection site bruising (4,409)

What Other Drugs Cause Leukaemia?

RANITIDINE (1,040) VENETOCLAX (385) RUXOLITINIB (321) IMATINIB (242) ADALIMUMAB (239) LENALIDOMIDE (219) NILOTINIB (176) CLOZAPINE (156) METHOTREXATE (142) ETANERCEPT (139)

Which EVOLOCUMAB Alternatives Have Lower Leukaemia Risk?

EVOLOCUMAB vs EXELON EVOLOCUMAB vs EXEMESTANE EVOLOCUMAB vs EXENATIDE EVOLOCUMAB vs EXFORGE EVOLOCUMAB vs EXJADE

Related Pages

EVOLOCUMAB Full Profile All Leukaemia Reports All Drugs Causing Leukaemia EVOLOCUMAB Demographics